RGS10 mitigates high glucose-induced microglial inflammation via the reactive oxidative stress pathway and enhances synuclein clearance in microglia
Authors:
Open Access
- 15 May 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 18, 1374298
Abstract
Microglia play a critical role in maintaining brain homeostasis but become dysregulated in neurodegenerative diseases. Regulator of G-protein Signaling 10 (RGS10), one of the most abundant homeostasis proteins in microglia, decreases with aging and functions as a negative regulator of microglia activation. RGS10-deficient mice exhibit impaired glucose tolerance, and high-fat diet induces insulin resistance in these mice. In this study, we investigated whether RGS10 modulates microglia activation in response to hyperglycemic conditions, complementing our previous findings of its role in inflammatory stimuli. In RGS10 knockdown (KD) BV2 cells, TNF production increased significantly in response to high glucose, particularly under proinflammatory conditions. Additionally, glucose uptake and GLUT1 mRNA levels were significantly elevated in RGS10 KD BV2 cells. These cells produced higher ROS and displayed reduced sensitivity to the antioxidant N-Acetyl Cysteine (NAC) when exposed to high glucose. Notably, both BV2 cells and primary microglia that lack RGS10 exhibited impaired uptake of alpha-synuclein aggregates. These findings suggest that RGS10 acts as a negative regulator of microglia activation not only in response to inflammation but also under hyperglycemic conditions.Keywords
This publication has 53 references indexed in Scilit:
- Glucose metabolism impairment in Parkinson’s diseaseBrain Research Bulletin, 2023
- Hallmarks of neurodegenerative diseasesCell, 2023
- Contribution of hyperglycemia-induced changes in microglia to Alzheimer’s disease pathologyPharmacological Reports, 2022
- RGS10 physically and functionally interacts with STIM2 and requires store-operated calcium entry to regulate pro-inflammatory gene expression in microgliaCellular Signalling, 2021
- The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative DiseasesImmunity, 2017
- Microglial Inflammatory Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates Obesity SusceptibilityCell Metabolism, 2017
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- Microglia: biology and pathologyActa Neuropathologica, 2009
- Glucose metabolism and insulin receptor signal transduction in Alzheimer diseaseEuropean Journal of Pharmacology, 2004
- New insights into the metabolic and molecular basis for diabetic neuropathyCellular and Molecular Life Sciences, 2003